Atinvicitinib

DB21558ExperimentalSmall molecule

Atinvicitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Atinvicitinib is a Janus kinase inhibitor. Atinvicitinib has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Janus (JAK) kinases
Curator reviewed
Formula / weight: C₁₆H₁₇FN₆O₃ · 360.349 g/mol (avg)

Resolves to

Compound

UNIIC238YE66P2CAS2169273-59-8ChEMBLCHEMBL4066193ChEBI756562PubChem135138184

Clinical / RWD

RxNorm2737481

Structure

InChIKeyPRQMBGDYXWVEHE-SKDRFNHKSA-NSMILESCOC1=NC(F)=CC(NC2=NN(C=C2C(N)=O)[C@H]2COCC[C@@H]2C#N)=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Atinvicitinib, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account